SCHEMBL9954881

SCHEMBL9954881

O=c1c2cc(I)ccc2nc(Cl)n1-c1ccc(N2CCOCC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDO2 P48775 1/20 0.52
IDO2 Q6ZQW0 1/20 0.52
MAT2A P31153 1/20 0.42
AKR1C3 P42330 1/20 0.42
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 4/20 0.41
POLB P06746 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PIK3CD O00329 2/20 0.41
PIK3CA P42336 2/20 0.41
PIK3CB P42338 2/20 0.41
PIK3CG P48736 1/20 0.41
PRKDC P78527 1/20 0.41
ESR2 Q92731 1/20 0.41
PDE3B Q13370 1/20 0.40
PDE3A Q14432 1/20 0.40
CYP1A2 P05177 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9954672 0.85 TDO2 (0.52) TDO2IDO2AKR1C3MEN1KMT2A
SCHEMBL10517573 0.84 NPC1 (0.46) MEN1KMT2AALDH1A1KDM4EPOLB
SCHEMBL9954457 0.83 HCAR1 (0.50) ESR2NPC1RAB9ASMN1; SMN2MAPK1
SCHEMBL9954122 0.82 ESR2 (0.44) MEN1KMT2APOLBESR2NPC1
SCHEMBL9954576 0.79 ESR2 (0.41) POLBESR2NPC1
SCHEMBL9955025 0.79 ESR2 (0.41) POLBESR2NPC1
SCHEMBL9953129 0.77 POLB (0.41) TDO2IDO2POLBPIK3CDESR2
SCHEMBL9953965 0.77 POLB (0.41) MEN1KMT2APOLBESR2NPC1
SCHEMBL9953877 0.75 POLB (0.54) MEN1KMT2AALDH1A1POLBESR2
SCHEMBL9954657 0.74 HPD (0.44) TDO2IDO2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012087938-A1 QUINAZOLINONE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-06-28 WO disclosed
WO-2012087938-A1 QUINAZOLINONE DERIVATIVES AS ANTIVIRAL AGENTS GLAXOSMITHKLINE LLC (US) 2012-06-28 WO disclosed